Literature DB >> 10699698

Smaller tidal volumes with room-air are not sufficient to ensure adequate oxygenation during bag-valve-mask ventilation.

V Dörges1, H Ocker, S Hagelberg, V Wenzel, A H Idris, P Schmucker.   

Abstract

The European Resuscitation Council has recommended decreasing tidal volume during basic life support ventilation from 800 to 1200 ml, as recommended by the American Heart Association, to 500 ml in order to minimise stomach inflation. However, if oxygen is not available at the scene of an emergency, and small tidal volumes are given during basic life support ventilation with a paediatric self-inflatable bag and room-air (21% oxygen), insufficient oxygenation and/or inadequate ventilation may result. When apnoea occurred after induction of anaesthesia, 40 patients were randomly allocated to room-air ventilation with either an adult (maximum volume, 1500 ml) or paediatric (maximum volume, 700 ml) self-inflatable bag for 5 min before intubation. When using an adult (n=20) versus paediatric (n=20) self-inflatable bag, mean +/-SEM tidal volumes and tidal volumes per kilogram were significantly (P<0.0001) larger (719+/-22 vs. 455+/-23 ml and 10.5+/-0.4 vs. 6.2+/-0.4 ml kg(-1), respectively). Compared with an adult self-inflatable bag, bag-valve-mask ventilation with room-air using a paediatric self-inflatable bag resulted in significantly (P<0.01) lower paO(2) values (73+/-4 vs. 87+/-4 mmHg), but comparable carbon dioxide elimination (40+/-2 vs. 37+/-1 mmHg; NS). In conclusion, our results indicate that smaller tidal volumes of approximately 6 ml kg(-1) ( approximately 500 ml) given with a paediatric self-inflatable bag and room-air maintain adequate carbon dioxide elimination, but do not result in sufficient oxygenation during bag-valve-mask ventilation. Thus, if small (6 ml kg(-1)) tidal volumes are being used during bag-valve-mask ventilation, additional oxygen is necessary. Accordingly, when additional oxygen during bag-valve-mask ventilation is not available, only large tidal volumes of approximately 11 ml kg(-1) were able to maintain both sufficient oxygenation and carbon dioxide elimination.

Entities:  

Mesh:

Year:  2000        PMID: 10699698     DOI: 10.1016/s0300-9572(99)00161-6

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  6 in total

1.  Emergency airway management by non-anaesthesia house officers--a comparison of three strategies.

Authors:  V Dörges; H Ocker; V Wenzel; C Sauer; P Schmucker
Journal:  Emerg Med J       Date:  2001-03       Impact factor: 2.740

2.  Emergency airway management by intensive care unit nurses with the intubating laryngeal mask airway and the laryngeal tube.

Authors:  V Dörges; V Wenzel; E Neubert; P Schmucker
Journal:  Crit Care       Date:  2000-10-13       Impact factor: 9.097

3.  Comparing Surf Lifeguards and Nurse Anesthetists' Use of the i-gel Supraglottic Airway Device - An Observational Simulation Study.

Authors:  Louise Nørkjær; Mathilde Stærk; Kasper G Lauridsen; Tabita K Gallacher; Jakob B Løyche; Kristian Krogh; Bo Løfgren
Journal:  Open Access Emerg Med       Date:  2020-04-02

4.  Effect of Early Supraglottic Airway Device Insertion on Chest Compression Fraction during Simulated Out-of-Hospital Cardiac Arrest: Randomised Controlled Trial.

Authors:  Loric Stuby; Laurent Jampen; Julien Sierro; Maxime Bergeron; Erik Paus; Thierry Spichiger; Laurent Suppan; David Thurre
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.241

5.  Part 2. Adult basic life support: 2015 Korean Guidelines for Cardiopulmonary Resuscitation.

Authors:  Keun Jeong Song; Jae-Bum Kim; Jinhee Kim; Chanwoong Kim; Sun Young Park; Chang Hee Lee; Yong Soo Jang; Gyu Chong Cho; Youngsuk Cho; Sung Phil Chung; Sung Oh Hwang
Journal:  Clin Exp Emerg Med       Date:  2016-07-05

6.  Effect on Chest Compression Fraction of Continuous Manual Compressions with Asynchronous Ventilations Using an i-gel® versus 30:2 Approach during Simulated Out-of-Hospital Cardiac Arrest: Protocol for a Manikin Multicenter Randomized Controlled Trial.

Authors:  Loric Stuby; Laurent Jampen; Julien Sierro; Erik Paus; Thierry Spichiger; Laurent Suppan; David Thurre
Journal:  Healthcare (Basel)       Date:  2021-03-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.